Pentafluorosulpholane-containing antidiabetic compounds

Details for Australian Patent Application No. 2010206783 (hide)

Owner Schering Corporation

Inventors Josien, Hubert B.; Clader, John W.; Stamford, Andrew; Greenlee, William J.; Mayer, Michael John; Davis, Jason L.; Hsia, Ming Min; Wan, Shuangyi

Agent Spruson & Ferguson

Pub. Number AU-A-2010206783

PCT Pub. Number WO2010/085522

Priority 61/146,833 23.01.09 US

Filing date 21 January 2010

Wipo publication date 29 July 2010

International Classifications

C07D 277/34 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/085522 Priority application(s): WO2010/085522

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206786-Bridged and fused heterocyclic antidiabetic compounds

2010206770-Stimulation channel conditioning